{"id":"n_khg5uqj2dki7izx7wtyq","seq":10439334,"kind":"article","title":"FDA Grants Breakthrough Therapy Designation to 64Cu-SAR-bisPSMA for PSMA PET in Biochemically Recurrent Prostate Cancer","url":"https://www.onclive.com/view/fda-grants-breakthrough-therapy-designation-to-64cu-sar-bispsma-for-psma-pet-in-biochemically","published":"2026-11-12T15:52:00Z","seen":"2026-11-12T20:50:35Z","lang":"en","source":{"id":"onclive.com","name":"onclive.com","domain":"onclive.com"},"via":"gdelt-gkg-english","topics":["economy","health"],"story":"st_rczcaihv4rz3rdqhax6q","category":"health","category_p":0.51,"sentiment":"positive","tone":0.0,"political":0.08}